Guardian Pharmacy Services (GRDN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $39.68, -2.22% vs the prior close of $40.58.
- Volume 444.00K shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
GRDN dips 2.2% to $39.68, a 1-month low. Closed at $39.68, -2.22% vs the prior close of $40.58. Day range $39.26–$41.22, opened at $40.87.
GRDN daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — GRDN dips 2.2% to $39.68, a 1-month low
- Closed at $39.68, -2.22% vs the prior close of $40.58. Day range $39.26–$41.22, opened at $40.87.
- Volume was 444.00K shares, 0.8x its 50-day average of 542.02K.
- Price is -3.0% vs its 50-day average ($40.89) and +5.6% vs its 200-day average ($37.57).
- 52-week range $23.37–$48.33; today's close sits at 65% of that range, 17.9% below the 52-week high.
Oct 14, 2026 — GRDN rises 1.9% to $40.58
- Closed at $40.58, +1.93% vs the prior close of $39.81. Day range $39.30–$40.59, opened at $39.56.
- Volume was 390.70K shares, 0.7x its 50-day average of 538.22K.
- Price is -0.8% vs its 50-day average ($40.90) and +8.1% vs its 200-day average ($37.53).
- 52-week range $23.37–$48.33; today's close sits at 69% of that range, 16.0% below the 52-week high.
Oct 13, 2026 — GRDN dips 1.6% to $39.81, a 1-month low, 3 down days in a row
- Closed at $39.81, -1.63% vs the prior close of $40.47. Day range $39.63–$40.77, opened at $40.77.
- Volume was 300.40K shares, 0.6x its 50-day average of 537.15K — lighter than usual.
- Price is -2.7% vs its 50-day average ($40.90) and +6.2% vs its 200-day average ($37.48).
- 52-week range $23.37–$48.33; today's close sits at 66% of that range, 17.6% below the 52-week high.
- That makes 3 straight losses.
Oct 12, 2026 — GRDN dips 2.0% to $40.47, a 1-month low
- Closed at $40.47, -1.96% vs the prior close of $41.28. Day range $39.13–$40.61, opened at $40.61.
- Volume was 733.20K shares, 1.4x its 50-day average of 531.12K.
- Price is -1.1% vs its 50-day average ($40.92) and +8.1% vs its 200-day average ($37.43).
- 52-week range $23.14–$48.33; today's close sits at 69% of that range, 16.3% below the 52-week high.
Oct 9, 2026 — GRDN dips 0.8% to $41.28
- Closed at $41.28, -0.77% vs the prior close of $41.60. Day range $40.67–$41.47, opened at $41.43.
- Volume was 397.50K shares, 0.8x its 50-day average of 527.00K.
- Price is +0.9% vs its 50-day average ($40.90) and +10.4% vs its 200-day average ($37.39).
- 52-week range $23.14–$48.33; today's close sits at 72% of that range, 14.6% below the 52-week high.
Oct 8, 2026 — GRDN rises 2.3% to $41.60
- Closed at $41.60, +2.26% vs the prior close of $40.68. Day range $40.19–$41.80, opened at $40.79.
- Volume was 574.10K shares, 1.1x its 50-day average of 520.71K.
- Price is +1.7% vs its 50-day average ($40.90) and +11.4% vs its 200-day average ($37.34).
- 52-week range $23.14–$48.33; today's close sits at 73% of that range, 13.9% below the 52-week high.
Oct 7, 2026 — GRDN dips 1.3% to $40.68, 3 down days in a row
- Closed at $40.68, -1.26% vs the prior close of $41.20. Day range $40.35–$41.98, opened at $40.77.
- Volume was 388.30K shares, 0.8x its 50-day average of 516.96K.
- Price is -0.5% vs its 50-day average ($40.89) and +9.1% vs its 200-day average ($37.29).
- 52-week range $23.14–$48.33; today's close sits at 70% of that range, 15.8% below the 52-week high.
- That makes 3 straight losses.
Oct 6, 2026 — GRDN dips 2.1% to $41.20
- Closed at $41.20, -2.14% vs the prior close of $42.10. Day range $40.80–$42.95, opened at $42.30.
- Volume was 388.60K shares, 0.8x its 50-day average of 515.51K.
- Price is +0.7% vs its 50-day average ($40.91) and +10.6% vs its 200-day average ($37.24).
- 52-week range $23.14–$48.33; today's close sits at 72% of that range, 14.8% below the 52-week high.
Oct 5, 2026 — GRDN dips 0.7% to $42.10
- Closed at $42.10, -0.66% vs the prior close of $42.38. Day range $42.08–$42.74, opened at $42.60.
- Volume was 276.00K shares, 0.5x its 50-day average of 515.02K — lighter than usual.
- Price is +2.9% vs its 50-day average ($40.92) and +13.2% vs its 200-day average ($37.19).
- 52-week range $23.14–$48.33; today's close sits at 75% of that range, 12.9% below the 52-week high.
Oct 2, 2026 — GRDN jumps 3.8% to $42.38, 3 up days in a row
- Closed at $42.38, +3.77% vs the prior close of $40.84. Day range $40.86–$42.44, opened at $41.10.
- Volume was 542.30K shares, 1.0x its 50-day average of 519.54K.
- Price is +3.7% vs its 50-day average ($40.89) and +14.1% vs its 200-day average ($37.13).
- 52-week range $23.14–$48.33; today's close sits at 76% of that range, 12.3% below the 52-week high.
- That makes 3 straight gains.
GRDN latest news & SEC filings
Every SEC filing by or about GRDN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mudd William Franklin converted options/RSUs into 38,282 shares on Sep 27, 2026; now holds 136,747
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Weir Robert converted options/RSUs into 23,450 shares on Sep 27, 2026; now holds 103,333
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ackerman John converted options/RSUs into 1,413,939 shares on Sep 27, 2026; now holds 3,863,806
- Ackerman John converted options/RSUs into 471,057 shares on Sep 27, 2026; now holds 1,287,237
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Salentine Thomas J Jr converted options/RSUs into 6,100,175 shares on Sep 27, 2026; now holds 16,669,666
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Martin David Norman converted options/RSUs into 39,865 shares on Sep 27, 2026; now holds 140,905
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Pharmacy Investors, Llc converted options/RSUs into 1,413,939 shares on Sep 27, 2026; now holds 3,863,806
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 28, 2026 · Form SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 10, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $351.77M (prior year $344.33M) (+2.2% vs Jun 30, 2025)
- Net income: $21.87M (prior year $9.03M) (+142.2% vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Things to know before you trade GRDN
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 6, 2026, Mar 11, 2026, Jan 13, 2026. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.57% (largest 3.8%).
- Liquidity: about 620.59K shares (≈$24.62M) trade per day on average.
- 52-week position: $39.68 vs a range of $23.37–$48.33 (65% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 1 open-market buys, 10 sales; latest: William E Bindley sold 3,570,677 shares on Mar 20, 2026.
- Latest filings: 8-K Sep 10, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Listing: NYSE · industry: Retail-Drug Stores and Proprietary Stores.
GRDN market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 40.87 | 41.22 | 39.26 | 39.68 | 444.00K |
| Oct 14, 2026 | 39.56 | 40.59 | 39.30 | 40.58 | 390.70K |
| Oct 13, 2026 | 40.77 | 40.77 | 39.63 | 39.81 | 300.40K |
| Oct 12, 2026 | 40.61 | 40.61 | 39.13 | 40.47 | 733.20K |
| Oct 9, 2026 | 41.43 | 41.47 | 40.67 | 41.28 | 397.50K |
| Oct 8, 2026 | 40.79 | 41.80 | 40.19 | 41.60 | 574.10K |
| Oct 7, 2026 | 40.77 | 41.98 | 40.35 | 40.68 | 388.30K |
| Oct 6, 2026 | 42.30 | 42.95 | 40.80 | 41.20 | 388.60K |
| Oct 5, 2026 | 42.60 | 42.74 | 42.08 | 42.10 | 276.00K |
| Oct 2, 2026 | 41.10 | 42.44 | 40.86 | 42.38 | 542.30K |
| Oct 1, 2026 | 40.66 | 41.24 | 40.04 | 40.84 | 498.10K |
| Sep 30, 2026 | 41.23 | 41.89 | 40.54 | 40.78 | 540.20K |
| Sep 29, 2026 | 40.48 | 40.89 | 40.19 | 40.68 | 488.20K |
| Sep 28, 2026 | 41.12 | 42.42 | 40.09 | 40.74 | 621.50K |
| Sep 25, 2026 | 41.70 | 42.34 | 41.19 | 41.21 | 720.60K |
| Sep 24, 2026 | 43.09 | 43.82 | 41.50 | 41.79 | 494.40K |
| Sep 23, 2026 | 44.65 | 45.07 | 43.17 | 43.26 | 440.80K |
| Sep 22, 2026 | 44.36 | 45.37 | 44.36 | 44.67 | 396.90K |
| Sep 21, 2026 | 45.14 | 45.14 | 43.34 | 44.16 | 570.30K |
| Sep 18, 2026 | 45.01 | 45.64 | 44.24 | 44.99 | 3.21M |
About Guardian Pharmacy Services
Guardian Pharmacy Services (GRDN) is listed on the NYSE and classified by the SEC under “Retail-Drug Stores and Proprietary Stores”. Its business address is in ATLANTA, GA. State of incorporation: GA. Fiscal year ends December 31. SEC CIK 1802255.
GRDN board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| John Ackerman | Member of 10% Owner Group | Sep 28, 2026 |
| William E Bindley | Member of 10% Owner Group | Sep 28, 2026 |
| Fred Burke | See Remarks | Sep 28, 2026 |
| Steven D Cosler | Director | May 7, 2026 |
| Randall J Lewis | Director | May 7, 2026 |
| David K Morris | See Remarks | Sep 28, 2026 |
| Mary Sue Patchett | Director | May 7, 2026 |
| Thomas J Jr Salentine | Member of 10% Owner Group | Sep 28, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Fred Burke | See Remarks | Sep 28, 2026 |
| Chris Crisafulli | See Remarks | Sep 28, 2026 |
| Richard Eakins | Senior Vice President, Sales | Sep 28, 2026 |
| David Norman Martin | See Remarks | Sep 28, 2026 |
| David K Morris | See Remarks | Sep 28, 2026 |
| William Franklin Mudd | See Remarks | Sep 28, 2026 |
| Douglas Towns | See Remarks | Sep 28, 2026 |
| Jeffrey Tuch | See Remarks | Sep 28, 2026 |
| Robert Weir | See Remarks | Sep 28, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Mar 20, 2026 | William E Bindley | Sale | 3,570,677 | $29.68 |
| Mar 20, 2026 | Capital Partners I, Llc Bindley | Sale | 3,570,677 | $29.68 |
| Mar 20, 2026 | Thomas J Jr Salentine | Sale | 3,570,677 | $29.68 |
| Mar 20, 2026 | Kendall Forbes | Sale | 346,672 | $29.68 |
| Mar 20, 2026 | John Ackerman | Sale | 275,728 | $29.68 |
| Mar 20, 2026 | John Ackerman | Sale | 827,636 | $29.68 |
| Mar 20, 2026 | David K Morris | Sale | 187,855 | $29.68 |
| Mar 20, 2026 | Fred Burke | Sale | 671,432 | $29.68 |
| Mar 20, 2026 | Investors, Llc Pharmacy | Sale | 827,636 | $29.68 |
| Mar 20, 2026 | Equity Fund, L.P. Cardinal | Sale | 275,728 | $29.68 |
| Dec 3, 2025 | Steven D Cosler | Buy | 3,370 | $29.61 |
GRDN financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.45B | $49.22M | — | $100.25M |
| Dec 31, 2024 | $1.23B | $-110.05M | — | $57.96M |
Latest balance sheet: total assets $443.58M, total liabilities $185.94M, cash $89.81M (as of Jun 30, 2026).
GRDN earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $39.47 |
| May 6, 2026 | 8-K Item 2.02 (results) | $36.58 |
| Mar 11, 2026 | 8-K Item 2.02 (results) | $33.51 |
| Jan 13, 2026 | 8-K Item 2.02 (results) | $31.26 |
| Nov 10, 2025 | 8-K Item 2.02 (results) | $29.75 |
| Aug 11, 2025 | 8-K Item 2.02 (results) | $19.88 |
| May 12, 2025 | 8-K Item 2.02 (results) | $25.66 |
| Mar 26, 2025 | 8-K Item 2.02 (results) | $20.23 |
| Mar 3, 2025 | 8-K Item 2.02 (results) | $18.91 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $22.18 |
Related stocks · Retail-Drug Stores and Proprietary Stores
Cvs Health (CVS)111 (YI)Petmed Express (PETS)Ridgetech (RDGT)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on GRDN
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.